BMY

Bristol-Myers Squibb Company · Healthcare · Drug Manufacturers - General
$66.05
+1.42 (+2.20%)
Mkt Cap: 134.92B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield11.7%
Dividend YieldN/A
Market Cap134.92B
Volume6.61M
Recent News
3 Absurdly Cheap Dividend Stocks to Buy for Under $100 Right Now
fool.com · 2026-08-18
Can BMY's First CELMoD Approval Support Its Growth Strategy?
zacks.com · 2026-08-14
AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?
fool.com · 2026-08-14
Fidelity Healthcare ETF vs. iShares Pharma Fund: Which Wins?
fool.com · 2026-08-14
Is the Reported $400 Billion AstraZeneca-Bristol Myers Squibb Megamerger a Slam Dunk -- or a Disaster Waiting to Happen?
fool.com · 2026-08-13
U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse
businesswire.com · 2026-08-13

Unlock the Full Deep Scan

9 AI agents analyze BMY across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →